End-of-day quote
Korea S.E.
23:00:00 03/06/2024 BST
5-day change
1st Jan Change
10,090
KRW
+0.20%
+3.81%
-0.88%
L&K Biomed Ltd. announced that it has received KRW 20 billion in funding from NH Investment & Securities Co., Ltd., Asset Management Arm, BNK Securities Co., Ltd., Investment Arm, Core Trend Investment Ltd., Kiwoom Securities Co., Ltd., Investment Arm and other investors
On July 16, 2021, L&K Biomed Ltd. closed the transaction.
L&K Biomed Ltd. announced that it has received KRW 20 billion in funding from a group of investors
05-08
CI
L&K Biomed Ltd. announced that it expects to receive KRW 20 billion in funding from a group of investors
05-06
CI
RootLoc Co., Ltd. announced that it has received KRW 3.686515722 billion in funding from L&K Biomed Ltd.
10/09/23
CI
RootLoc Co., Ltd. announced that it expects to receive KRW 3.686515722 billion in funding from L&K Biomed Ltd.
31/08/23
CI
L&K Biomed to Raise 36.6 Billion Won via Shares Issuance; Shares Plunge 23%
15/05/23
MT
L&K Biomed Ltd.(KOSDAQ:A156100) added to S&P Global BMI Index
20/09/21
CI
L&K Biomed Ltd. announced that it has received KRW 20 billion in funding from NH Investment & Securities Co., Ltd., Asset Management Arm, BNK Securities Co., Ltd., Investment Arm, Core Trend Investment Ltd., Kiwoom Securities Co., Ltd., Investment Arm and other investors
15/07/21
CI
L&K Biomed Ltd. announced that it expects to receive KRW 20 billion in funding from NH Investment & Securities Co., Ltd., Asset Management Arm, BNK Securities Co., Ltd., Investment Arm, Core Trend Investment Ltd., Kiwoom Securities Co., Ltd., Investment Arm and other investors
14/07/21
CI
Tranche Update on L&K Biomed Ltd.'s Equity Buyback Plan announced on May 30, 2017.
11/09/20
CI
Tranche Update on L&K Biomed Ltd.'s Equity Buyback Plan announced on May 30, 2017.
11/09/20
CI
Tranche Update on L&K Biomed Ltd.'s Equity Buyback Plan announced on May 30, 2017.
11/09/20
CI
Tranche Update on L&K Biomed Ltd.'s Equity Buyback Plan announced on May 30, 2017.
11/09/20
CI
Tranche Update on L&K Biomed Ltd.'s Equity Buyback Plan announced on May 30, 2017.
11/09/20
CI
L&K Biomed Ltd.'s Equity Buyback announced on May 30, 2017, has expired with 361,567 shares, representing 3.88% for KRW 2,986.18 million.
10/09/20
CI
L&K Biomed Ltd.'s Equity Buyback Plan Extended till November 30, 2020.
28/11/19
CI
Tranche Update on L&K Biomed Ltd.'s Equity Buyback Plan announced on May 30, 2017.
29/06/19
CI
L&K Biomed Ltd.'s Equity Buyback Plan Extended till November 30, 2019.
30/05/19
CI
Tranche Update on L&K Biomed Ltd.'s Equity Buyback Plan announced on May 30, 2017.
30/03/19
CI
Tranche Update on L&K Biomed Ltd.'s Equity Buyback Plan announced on May 30, 2017.
04/03/19
CI
Tranche Update on L&K Biomed Ltd.'s Equity Buyback Plan announced on May 30, 2017.
04/03/19
CI
L&K Biomed Ltd.'s Equity Buyback Plan Extended till May 31, 2019.
29/11/18
CI
Tranche Update on L&K Biomed Ltd.'s Equity Buyback Plan announced on May 30, 2017.
05/09/18
CI
Tranche Update on L&K Biomed Ltd.'s Equity Buyback Plan announced on May 30, 2017.
05/09/18
CI
L&K Biomed Ltd.'s Equity Buyback Plan Extended till November 30, 2018.
30/05/18
CI
L&K Biomed Ltd. announced that it expects to receive KRW 16.99996803 billion in funding from ValueSystem Investment Management Corp., Susung Asset Management Co., Ltd., W Asset Management Co., Ltd., Orion Capital Management
24/05/18
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
L&K BIOMED CO., LTD. is a Korea-based company mainly engaged in the research, development and manufacture of medical devices. The Companyâs products consist of medical devices and medical equipment. Its medical devices include cervical spine products, such as cervical plate systems, cervical screw systems and cervical cage system, as well as thoracolumbar spine products and others. Its medical equipment includes three dimensional (3D) full-body scanners. It also engages in the bio-similar business, which develops cell engineering.
More about the company
1st Jan change
Capi.
-0.88% 146M +14.21% 130B -3.76% 11.09B -1.95% 8.56B +40.43% 5.62B -27.04% 4.41B +7.47% 3.41B -15.26% 2.6B -12.01% 2.07B -13.56% 1.92B
Medical Devices & Implants
Stock Market Equities A156100 Stock
News L&K Biomed Ltd. L&K Biomed Ltd. announced that it has received KRW 20 billion in funding from NH Investment & Securities Co., Ltd., Asset Management Arm, BNK Securities Co., Ltd., Investment Arm, Core Trend Investment Ltd., Kiwoom Securities Co., Ltd., Investment Arm and other investors
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1